SCHEMBL7680067

SCHEMBL7680067

CC(C)c1cccc2c1CN(C(CCC(N)=O)C(=O)O)C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
NFKB1 P19838 1/20 0.40
APEX1 P27695 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SDCBP O00560 6/20 0.38
SDC2 P34741 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677784 0.91 KDM4E (0.50) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL7671077 0.88 ALOX15 (0.43) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL7679807 0.86 KDM4E (0.42) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL7672799 0.86 ALOX15 (0.47) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL7675322 0.85 ALOX15 (0.46) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL30001202 0.85 ALOX15 (0.46) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL502389 0.85 ALOX15 (0.46) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL2250406 0.85 MEN1 (0.48) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL2381406 0.84 ALOX15 (0.47) ALOX15KDM4EMEN1KMT2AMAPT
SCHEMBL22473770 0.84 ALOX15 (0.45) ALOX15KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
CN-1342146-A Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels CELGENE CORP (US) 2002-03-27 CN disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed